The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 13, 2018

Filed:

May. 05, 2017
Applicant:

Chun-ching Shih, Taichung, TW;

Inventors:

Chun-Ching Shih, Taichung, TW;

Yueh-Hsiung Kuo, Taichung, TW;

Cheng-Hsiu Lin, Taichung, TW;

Chang-Syun Yang, Taichung, TW;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/575 (2006.01); A61K 36/07 (2006.01); A61P 3/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/575 (2013.01); A61K 36/07 (2013.01); A61P 3/00 (2018.01);
Abstract

Provided is a method of treating metabolic diseases including type 2 diabetes, insulin resistance, hyperglycemia, hyperlipidemia, obesity, hepatic steatosis, and hyperinsulinemia in a subject in need, including the step of administering to the subject a therapeutically effective amount of antcin K. Also provided is a method of enhancing protein expression ratio of phospho-5' adenosine monophosphate-activated protein kinase (phospho-AMPK) to total AMPK in skeletal muscle or liver of a subject, and a method of reducing blood leptin in a subject. Antcin K exerts prominent antidiabetic and antihyperlipidemic effects through regulation of membrane GLUT4, AMPK, Akt PPARα, FAS, and PPARγ protein expressions and G6Pase, DGAT2, SREBP-1c, aP2, apoCIII, SREBP2, and PPARα mRNA expressions.


Find Patent Forward Citations

Loading…